Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Liver Embolization.

Debashish Bose is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Bose is rated as an Experienced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Pancreatic Pseudocyst, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Bose is currently accepting new patients.

Joseph Bennett is a General Surgeon and a Surgical Oncologist in Randallstown, Maryland. Dr. Bennett is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Pancreatic Adenoma, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Bennett is currently accepting new patients.

Richard Schraeder is a Hematologist Oncology specialist and a Hematologist in Towson, Maryland. Dr. Schraeder is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Retroperitoneal Liposarcoma. Dr. Schraeder is currently accepting new patients.

Roopa Gupta is a Hematologist Oncology specialist and an Oncologist in Easton, Maryland. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Childhood Iron Deficiency Anemia, Paget Disease of the Breast, Inflammatory Breast Cancer, and Thrombocytopenia. Dr. Gupta is currently accepting new patients.

Philip Nivatpumin is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Nivatpumin is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Anal Cancer, and Small Cell Lung Cancer (SCLC).

Xin Zhong is a General Surgeon in Berlin, Maryland. Dr. Zhong is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Retroperitoneal Inflammation, Hernia, Gallbladder Disease, Hernia Surgery, and Sleeve Gastrectomy. Dr. Zhong is currently accepting new patients.

Mark Mishra is a Radiation Oncologist in Baltimore, Maryland. Dr. Mishra is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Metastatic Brain Tumor, Astrocytoma, Brain Tumor, Meningioma, and Prostatectomy. Dr. Mishra is currently accepting new patients.

Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.

Ilene S. Browner, M.D. specializes in geriatric oncology. Dr. Browner is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Endoscopy.

Panayotis Ledakis is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Ledakis is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Appendix Cancer, Desmoplastic Small Round Cell Tumor, Anemia, Colorectal Cancer, and Ureteroscopy. Dr. Ledakis is currently accepting new patients.

Glen Gibson is a Surgical Oncologist and a General Surgeon in Annapolis, Maryland. Dr. Gibson is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Familial Pancreatic Cancer, Melanoma, Familial Colorectal Cancer, Hernia Surgery, and Hepatectomy. Dr. Gibson is currently accepting new patients.

Nicholas Demonaco is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Demonaco is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Pulmonary Embolism, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Anemia. Dr. Demonaco is currently accepting new patients.

Asif Hitawala is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Hitawala is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Acute Febrile Neutrophilic Dermatosis, Gallbladder Adenocarcinoma, Non-Alcoholic Fatty Liver Disease, Gastrostomy, and Hormone Replacement Therapy (HRT).

Elhamy Eskander is an Oncologist and a Hematologist in Frederick, Maryland. Dr. Eskander is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Lung Cancer, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Autoimmune Hemolytic Anemia.

Jose Mendoza is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Mendoza is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Anemia, and Familial Colorectal Cancer. Dr. Mendoza is currently accepting new patients.

Mahsa Mohebtash is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Mohebtash is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. Dr. Mohebtash is currently accepting new patients.

Deepnarayan Tiwarri is a Hematologist Oncology specialist and a Hematologist in Clinton, Maryland. Dr. Tiwarri is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Pulmonary Embolism, and Anemia. Dr. Tiwarri is currently accepting new patients.

Richard Mackey is a Surgical Oncologist and a General Surgeon in Frederick, Maryland. Dr. Mackey is rated as an Advanced provider by MediFind in the treatment of Gallbladder Adenocarcinoma. His top areas of expertise are Choledocholithiasis, Retroperitoneal Liposarcoma, Familial Pancreatic Cancer, Hernia Surgery, and Pancreatectomy. Dr. Mackey is currently accepting new patients.